Medication Continuity Among Medicaid Beneficiaries with Schizophrenia and Bipolar Disorder

Medication Continuity Among Medicaid Beneficiaries with Schizophrenia and Bipolar Disorder

Published: Sep 01, 2013
Publisher: Psychiatric Services in Advance, vol. 64, issue 9
Download
Authors

Jonathan D. Brown

Allison Barrett

Emily Caffery

Henry T. Ireys

This study examines whether medication continuity among Medicaid beneficiaries with schizophrenia and bipolar disorder was associated with medication utilization management practices (prior authorization, copayment amounts, and refill and pill quantity limits); managed care enrollment; and other state and beneficiary characteristics. The study found that prior-authorization requirements and copayments for medications can present barriers to refilling medications for Medicaid beneficiaries with schizophrenia or bipolar disorder.

How do you apply evidence?

Take our quick four-question survey to help us curate evidence and insights that serve you.

Take our survey